|
|
|
|
|
|
|
|
|
|
Super Quote | Detail Quote | Interactive Chart | Transaction | Related News | Related Securities | Company Information | Dividend Records | Short Sell
01177 SINO BIOPHARM
Nominal 
5.810 -0.010 (-0.172%) Non-current Assets
| 2025/12 - Final RMB(K¥) | %Chg (Compare to Final) | 2024/12 RMB(K¥) | 2023/12 RMB(K¥) | 2022/12 RMB(K¥) | 2021/12 RMB(K¥) | |
| Investment Properties | -- | -- | 269,030 | 289,342 | 720,754 | 705,626 |
| Property, plant, equip. & others | -- | -- | 8,691,382 | 8,080,907 | 7,759,592 | 7,154,298 |
| Land & other Lease Assets | -- | -- | 1,596,774 | 1,831,254 | 1,491,591 | 1,361,764 |
| Intangible Assets | -- | -- | 3,060,966 | 2,908,961 | 1,914,450 | 1,711,946 |
| Interests in Asso. & JCEs | -- | -- | 1,620,085 | 12,243,675 | 13,198,157 | 14,266,396 |
| Other Non-current Assets | -- | -- | 25,484,501 | 14,445,149 | 13,044,835 | 11,840,129 |
| -- | -- | 40,722,738 | 39,799,288 | 38,129,379 | 37,040,159 | |
Current Assets
| 2025/12 - Final RMB(K¥) | %Chg (Compare to Final) | 2024/12 RMB(K¥) | 2023/12 RMB(K¥) | 2022/12 RMB(K¥) | 2021/12 RMB(K¥) | ||
| Inventories | -- | -- | 2,373,145 | 1,993,472 | 2,328,844 | 1,937,741 | |
| Trade Receivables | -- | -- | 4,967,560 | 4,510,195 | 4,638,396 | 4,220,667 | |
| Cash & Bank Balances | -- | -- | 9,569,584 | 9,451,878 | 12,066,217 | 10,568,812 | |
| Other Current Assets | -- | -- | 7,775,042 | 6,937,280 | 6,901,448 | 6,775,958 | |
| Assets Held for Sale | -- | -- | 0 | 912,706 | 0 | 0 | |
| -- | -- | 24,685,331 | 23,805,531 | 25,934,905 | 23,503,178 | ||
Current Liabilities
| 2025/12 - Final RMB(K¥) | %Chg (Compare to Final) | 2024/12 RMB(K¥) | 2023/12 RMB(K¥) | 2022/12 RMB(K¥) | 2021/12 RMB(K¥) | |||
| Trade Payables | -- | -- | 1,497,461 | 1,334,703 | 1,637,351 | 1,693,152 | ||
| S-T Debt & Leases | -- | -- | 7,630,401 | 11,207,428 | 9,723,841 | 6,585,038 | ||
| Other Current Liabilities | -- | -- | 10,428,628 | 9,825,785 | 8,789,485 | 7,066,829 | ||
| Liab asso w/ Assets Held for Sale | -- | -- | 0 | 238,859 | 0 | 0 | ||
| -- | -- | 19,556,490 | 22,606,775 | 20,150,677 | 15,345,019 | |||
| Net Current Assets | -- | -- | 5,128,841 | 1,198,756 | 5,784,228 | 8,158,159 | ||
| Total Assets Less Current Liabilities | -- | -- | 45,851,579 | 40,998,044 | 43,913,607 | 45,198,318 | ||
Non-current Liabilities
| 2025/12 - Final RMB(K¥) | %Chg (Compare to Final) | 2024/12 RMB(K¥) | 2023/12 RMB(K¥) | 2022/12 RMB(K¥) | 2021/12 RMB(K¥) | ||||
| L-T Debt & Leases | -- | -- | 2,080,145 | 1,372,816 | 4,258,122 | 5,532,475 | |||
| Other Non-current Liabilities | -- | -- | 997,364 | 1,455,275 | 1,711,937 | 1,936,820 | |||
| -- | -- | 3,077,509 | 2,828,091 | 5,970,059 | 7,469,295 | ||||
Capital and Reserves
| 2025/12 - Final RMB(K¥) | %Chg (Compare to Final) | 2024/12 RMB(K¥) | 2023/12 RMB(K¥) | 2022/12 RMB(K¥) | 2021/12 RMB(K¥) | |||||
| Share Capital | -- | -- | 414,384 | 414,615 | 414,899 | 415,440 | ||||
| Reserves | -- | -- | 31,546,405 | 30,059,854 | 29,332,136 | 29,875,676 | ||||
| Others | -- | -- | 0 | 0 | 0 | 0 | ||||
| Shareholders' Funds | -- | -- | 31,960,789 | 30,474,469 | 29,747,035 | 30,291,116 | ||||
| Non-controlling Interests | -- | -- | 10,813,281 | 7,695,484 | 8,196,513 | 7,437,907 | ||||
| Others | -- | -- | 0 | 0 | 0 | 0 | ||||
| -- | -- | 42,774,070 | 38,169,953 | 37,943,548 | 37,729,023 | |||||
Commitments and Contingent Liabilities
| 2025/12 - Final RMB(K¥) | %Chg (Compare to Final) | 2024/12 RMB(K¥) | 2023/12 RMB(K¥) | 2022/12 RMB(K¥) | 2021/12 RMB(K¥) | |
| Commitments | -- | -- | 1,517,577 | 535,546 | 1,811,239 | 950,038 |
| Contingent Liabilities | -- | -- | 0 | 0 | 0 | 0 |
| Remarks: | Real time quote last updated: 27/03/2026 13:35 |
| Real-time basic market prices of Hong Kong securities are provided by HKEx; a Designated Website authorized by the HKEx Group to provide the Service | |
| Profit / (Loss) Attributable to Shareholders (K¥) | RMB 2,343,348 |
| %Change | -33.044% |
| EPS / (LPS) | RMB 0.130 |
| NBV Per Share (¥) | RMB -- |